Firebrick Pharma (ASX:FRE) First Half 2025 Financial Overview

2 min read | February 25, 2025 01:33 PM AEDT | By Team Kalkine Media

Google News:

Firebrick Pharma (ASX:FRE) First Half 2025 Financial Overview

Recent News

Can ASX 200 Energy Transition Leaders Power Ahead?

Can Grid Firming Decide the Next Energy Winners?

Beyond the Banks: Which ASX Miners and Energy Names Are Quietly Paying...

Franking Credits and Income Strategies Across ASX 200 Dividend Portfol...

Make Kalkine Media
My Trusted Source

Highlights

Significant revenue drop to AU$197.1k from 1H 2024.

Net loss increased by 61% from the previous year.

Shares gained a slight increase over the past week.

The financial landscape of Firebrick Pharma (ASX:FRE) for the First Half of 2025 reveals some challenging developments. The company's revenue took a significant dip, down by 89% to AU$197.1k compared to the same period in 2024. Meanwhile, the net loss expanded by 61%, amounting to AU$1.45 million, marking a further struggle in meeting financial targets.

Additionally, the loss per share increased from AU$0.005 to AU$0.007, indicating a deteriorating financial position over the year. Despite these challenges, Firebrick Pharma's shares have shown a modest 1.2% gain from a week ago, noting some positive movement in the market.

Investors are advised to take note of the risk analyses as there are currently five warning signs associated with Firebrick Pharma, three of which are of particular concern. However, potential opportunities may be found using the new AI Stock Screener, which looks at various metrics to discover investment avenues.

For those interested in a deeper dive, the AI Stock Screener can help identify areas like dividend powerhouses, undervalued small caps with insider buying, and high-growth tech and AI companies. This tool allows users to customize their insights, using over 50 available metrics.

Stay informed and explore opportunities with the AI Stock Screener now available. It's crucial to note that all analyses are driven by historical data and current analyst forecasts, and are not personalized to individual financial situations or objectives.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.